Literature DB >> 23390060

The structure of azines derived from C-formyl-1H-imidazoles in solution and in the solid state: tautomerism, configurational and conformational studies.

Joana Pinto1, Vera L M Silva, Artur M S Silva, Rosa M Claramunt, Dionisia Sanz, M Carmen Torralba, M Rosario Torres, Felipe Reviriego, Ibon Alkorta, José Elguero.   

Abstract

The structures of three azines derived from 2-formylimidazole, 4(5)-formylimidazole, and 4(5)-formyl-5(4)-methylimidazole have been determined in solution and in the solid state. Density Functional Theory (DFT) Polarizable Continuum Model (PCM) calculations (geometries, energies, and chemical shifts), NMR [solution and cross polarization magic-angle spinning (CPMAS)], and X-ray crystallography [azine of 4(5)-formylimidazole] have been used. The configuration around the central C = N bonds has been determined and some insights about prototropic tautomerism and conformation have been gained.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23390060     DOI: 10.1002/mrc.3926

Source DB:  PubMed          Journal:  Magn Reson Chem        ISSN: 0749-1581            Impact factor:   2.447


  3 in total

1.  13C CPMAS NMR as a Tool for Full Structural Description of 2-Phenyl Substituted Imidazoles That Overcomes the Effects of Fast Tautomerization.

Authors:  Nikola Burdzhiev; Anife Ahmedova; Boris Borrisov; Robert Graf
Journal:  Molecules       Date:  2020-08-19       Impact factor: 4.411

2.  An experimental and theoretical NMR study of NH-benzimidazoles in solution and in the solid state: proton transfer and tautomerism.

Authors:  Carla I Nieto; Pilar Cabildo; M Ángeles García; Rosa M Claramunt; Ibon Alkorta; José Elguero
Journal:  Beilstein J Org Chem       Date:  2014-07-16       Impact factor: 2.883

3.  Crystal structure of 1,2-bis-[(1H-imidazol-2-yl)methylidene]hydrazine and its one-dimensional hydrogen-bonding network.

Authors:  Chia-Hwa Lee; Gene-Hsiang Lee
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.